Divi's Laboratories share news and announcements
NSE: DIVISLABBSE: 532488Pharmaceuticals & BiotechnologyLarge Cap
Last close ₹8,950.00down ₹212.00 (2.31%)BSE ₹8,984.00
Share price at the NSE close on 23 Oct 2026. Previous close ₹9,162.00.
52-week range of traded prices to 23 Oct 2026
₹5,647.50Low, 2 Apr 2026₹9,740.00High, 24 Sep 2026
- Next results date: the board meets on 7 Nov 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹2,37,594 Cr50th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 1 Aug 2026
- 81.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 27 May 2026
- 14.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.34%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 1 Aug 2026
- 18.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 1 Aug 2026
- 20.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 27 May 2026
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 6,20,26160.6% delivered
Divi's Laboratories share news and announcements
636 announcements, routine notices left out, newest first. Page 12 of 13.
Mar 2009
30 Mar · Updates
Abstract of terms being issued to the members of the company pursuant to Section 302 of the Companies Act,1956 regarding re-appointment of Whole-time Directors of the company. The details of the same shall be available on the NSE website http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2009
28 Jan · Legal
With reference to the mails and messages circulating regarding an alleged pledging of promoter's shareholding in the company with India Bulls or some institution that: "We hereby clarify and confirm that there is no pledge, whatsoever, of any shares held by the promoter in Divi's Laboratories Limited. Infact, the promoter does not have any loans from any bank or institution."24 Jan · Business
Press release, dated January 24, 2009 titled "Divi's Labs PAT for 9 months grows by 21% to Rs.309 crores". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.24 Jan · Allotment of Equity Shares
Compensation Committee of Board of Directors in its meeting held on January 24, 2009 made the allotment of 9500 equity shares of Rs. 2/- each to the employees under ESOP 2006 Scheme of the company. Consequent to the above allotment, the paid up share capital of the company will get increased to 64758025 equity shares from 64748525 equity shares of face value Rs. 2/- each.24 Jan · Results
Standalone Results for the quarter ended on 31-DEC-2008 as follows: Net Sales of Rs. 26742 lacs for quarter ending on 31-DEC-2008 against Rs. 33122 lacs for the quarter ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 8242 lacs for the quarter ending on 31-DEC-2008 against Rs. 13768 lacs for the quarter ending on 30-SEP-2008.24 Jan · Results
Consolidated Results for the quarter ended on 31-DEC-2008 as follows: Net Sales of Rs. 26475 lacs for quarter ending on 31-DEC-2008 against Rs. 28413 lacs for the quarter ending on 31-DEC-2007. Net Profit / (Loss) of Rs. 7953 lacs for the quarter ending on 31-DEC-2008 against Rs. 9906 lacs for the quarter ending on 31-DEC-2007.15 Jan · Board meeting
Meeting on 24 Jan 2009: “Unaudited Financial Results for the qtr ended Dec 31, 2008”
Nov 2008
3 Nov · Disclosure
Details as per the SEBI (Prohibition of Insider Trading) Regulation, 2002, regarding the insider, who is Director, has intimated the company on October 31, 2008, stating that his holding has changed consequent to the allotment of equity shares under Employee Stock Option Scheme 2006 of the company. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2008
30 Oct · Allotment of Equity Shares
Compensation Committee of Board of Directors in its meeting held on October 29, 2008 made the allotment of 24400 equity shares of Rs.2/- each to the employees under ESOP 2006 Scheme of the company. Consequent to the above allotment, the paid up share capital of the company will get increased to 64748525 equity shares from 64724125 equity shares of face value Rs.2/- each.29 Oct · Results
Consolidated Results for the half year ended on 30-SEP-2008 as follows: Net Sales of Rs. 59405 lacs for half year ending on 30-SEP-2008 against Rs. 47056 lacs for the half year ending on 30-SEP-2007. Net Profit / (Loss) of Rs. 22972 lacs for the half year ending on 30-SEP-2008 against Rs. 15586 lacs for the half year ending on 30-SEP-2007.29 Oct · Results
Consolidated Results for the quarter ended on 30-SEP-2008 as follows: Net Sales of Rs. 33047 lacs for quarter ending on 30-SEP-2008 against Rs. 24384 lacs for the quarter ending on 30-SEP-2007. Net Profit / (Loss) of Rs. 13539 lacs for the quarter ending on 30-SEP-2008 against Rs. 9097 lacs for the quarter ending on 30-SEP-2007.29 Oct · Results
Standalone Results for the half year ended on 30-SEP-2008 as follows: Net Sales of Rs. 59729 lacs for half year ending on 30-SEP-2008 against Rs. 47058 lacs for the half year ending on 30-SEP-2007. Net Profit / (Loss) of Rs. 23416 lacs for the half year ending on 30-SEP-2008 against Rs. 15853 lacs for the half year ending on 30-SEP-2007.29 Oct · Results
Standalone Results for the quarter ended on 30-SEP-2008 as follows: Net Sales of Rs. 33122 lacs for quarter ending on 30-SEP-2008 against Rs. 24251 lacs for the quarter ending on 30-SEP-2007. Net Profit / (Loss) of Rs. 13768 lacs for the quarter ending on 30-SEP-2008 against Rs. 9125 lacs for the quarter ending on 30-SEP-2007.29 Oct · Business
Press release, titled "Divi's Labs PAT for Q2 grows by 49% to Rs.135 crores". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.17 Oct · Board meeting
Inter-alia, to consider and take on record the un-audited financial results for the second quarter ended September 30, 2008.
Sep 2008
5 Sep · Disclosure
Details as per the SEBI (Prohibition of Insider Trading) Regulation, 2002.The insider who is Director, have intimated the company on September 04, 2008, stating that he has sold the equity shares held by him in the company. Name of Director: Dr. P Gundu Rao; Sell Quantity: 3000 equity shares. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Aug 2008
18 Aug · Meeting
Outcome of Annual General Meeting held on August 16, 2008.The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2008
26 Jul · Business
Press release, titled "Divi's Labs PAT for Q1 grows by 45% to Rs.94 crores". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.26 Jul · Results
Standalone Results for the quarter ended on 30-JUN-2008 as follows: Net Sales of Rs. 26607 lacs for quarter ending on 30-JUN-2008 against Rs. 22807 lacs for the quarter ending on 30-JUN-2007. Net Profit / (Loss) of Rs. 9648 lacs for the quarter ending on 30-JUN-2008 against Rs. 6728 lacs for the quarter ending on 30-JUN-2007.26 Jul · Results
Consolidated Results for the quarter ended on 30-JUN-2008 as follows: Net Sales of Rs. 26358 lacs for quarter ending on 30-JUN-2008 against Rs. 22672 lacs for the quarter ending on 30-JUN-2007. Net Profit / (Loss) of Rs. 9433 lacs for the quarter ending on 30-JUN-2008 against Rs. 6490 lacs for the quarter ending on 30-JUN-2007.26 Jul · Allotment of Equity Shares
Compensation Committee of Board of Directors in its meeting held on July 26, 2008 made the allotment of 51175 equity shares of Rs.2/- each to the employees under ESOP 2006 Scheme of the company. Consequent to the above allotment, the paid up share capital of the company will get increased to 64724125 equity shares from 64672950 equity shares of face value Rs.2/- each.17 Jul · Board meeting
Inter-alia, to consider and approve the un-audited financial results for the quarter ended June 30, 2008.
Jun 2008
12 Jun · Meeting
Share Transfer Books of the Company will remain closed from June 28, 2008 to July 04, 2008 (both days inclusive) for the purpose of the Annual General Meeting of the company scheduled to be held on August 16, 2008 and payment of dividend, if declared at the ensuing Annual General Meeting.9 Jun · Dividend
Board of Directors at their meeting held on June 07, 2008 has recommended a dividend of 200% on equity shares for the year ended March 31, 2008.9 Jun · Business
Press release, titled "Divi's Labs PAT for FY08 grows by 87% to Rs.348 crores". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.9 Jun · Results
Standalone Results for the year ended on 31-MAR-2008 as follows: Net Sales of Rs. 103319 lacs for year ending on 31-MAR-2008 against Rs. 72442 lacs for the year ending on 31-MAR-2007. Net Profit / (Loss) of Rs. 35356 lacs for the year ending on 31-MAR-2008 against Rs. 19174 lacs for the year ending on 31-MAR-2007.9 Jun · Results
Consolidated Results for the year ended on 31-MAR-2008 as follows: Net Sales of Rs. 103283 lacs for year ending on 31-MAR-2008 against Rs. 72458 lacs for the year ending on 31-MAR-2007. Net Profit / (Loss) of Rs. 34760 lacs for the year ending on 31-MAR-2008 against Rs. 18586 lacs for the year ending on 31-MAR-2007.9 Jun · Results
Consolidated Results for the quarter ended on 31-MAR-2008 as follows: Net Sales of Rs. 27814 lacs for quarter ending on 31-MAR-2008. Net Profit / (Loss) of Rs. 9268 lacs for the quarter ending on 31-MAR-2008.9 Jun · Results
Standalone Results for the quarter ended on 31-MAR-2008 as follows: Net Sales of Rs. 27839 lacs for quarter ending on 31-MAR-2008 against Rs. 25259 lacs for the quarter ending on 31-MAR-2007. Net Profit / (Loss) of Rs. 9437 lacs for the quarter ending on 31-MAR-2008 against Rs. 10098 lacs for the quarter ending on 31-MAR-2007.
May 2008
29 May · Board meeting
Company had informed the Exchange that a Meeting of the Board of Directors of the Company will be held on June 06, 2008 inter-alia, to consider and approve the audited financial results for the year ended March 31, 2008 and dividend on equity shares, if any, for the year. The Company has now informed the Exchange that the meeting of the Board of Directors of the Company has been postponed to June 07, 2008.28 May · Board meeting
Inter-alia, to consider and approve the audited financial results for the year ended March 31, 2008 and dividend on equity shares, if any, for the year.
Apr 2008
30 Apr · Disclosure
Two annual disclosure statements of employees and Directors of the Company for the year ended March 31, 2008 pursuant to the Regulation 13 of SEBI (Prohibition of Insider Trading) Regulations, 2002. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.28 Apr · Disclosure
As per the SEBI (Prohibition of Insider Trading) Regulations 2002, the following, who are Director ,have intimated the Company, stating that their holdings have changed consequent to the allotment of equity shares under Employee Stock Option Scheme 2006 of the Company: (1) Name of the Director : Mr N V Ramana - Executive Director; No. of Shares allotted: 59175; Date of allotment :- 19.04.2008; Balance holding : 329425; (2) Name of the Director : Dr P Gundu Rao - Director (R&D); No. of Shares allotted: 3550; Date of allotment :- 19.04.2008; Balance holding : 363521 Apr · Board meeting
Compensation Committee of Board of Directors in its meeting held on 19th April 2008 made the allotment of 115850 equity shares of Rs. 2/- each to the employees under ESOP 2006 Scheme of the company. Consequent to the above allotment, the paid up share capital of the company will get increased to 64672950 equity shares from 64557100 equity shares of face value Rs. 2/- each.15 Apr · Board meeting
Meeting of the Compensation Committee is scheduled to be held on April 19, 2008, to allot the equity shares to employees in pursuance of the ESOP 2006.11 Apr · Results
The Audited Financial Results of the Company for the entire financial year 2007-2008 shall be considered and published by the company within a period of three months from the end of the financial year, i.e. on or before 30th June 2008. Hence the Company is not considering the un-audited financial results for the last quarter of the financial year ended on 31st March, 2008.11 Apr · Disclosure
As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insider, who is Director / dependent family member of a Director, have intimated the company on 9th April 2008, stating that they have sold the equity shares held by them in the Company: (1) Name of the Director/Dependent Family Member : Dr. P Gundu Rao; No. of Shares Sold: 1200; Date of Execution :- 08.04.2008; Balance holding : 85; (2) Name of the Director/Dependent Family Member : Ms P Narmada Rao; No. of Shares Sold: 500; Date of Execution :- 08.04.2008; Balance holding : 25
Feb 2008
19 Feb · Updates
Divi's Laboratories is glad to announce that it has had a successful inspection by the US-FDA, without any observations, for its Unit-1 at vill. Lingojigudem, Choutuppal Mandal near Hyderabad during this month. The purpose of this inspection was for product pre-approval and general cGMP (Current Good Manufacturing Practices)12 Feb · Disclosure
As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insider, who is Director (Projects) of the company has intimated on 11th February 2008, stating that he has received gift of the following equity shares from his relative: (1) Name of the Director - Madhusudana Rao Divi; No. of Shares :- 20000; Date of Execution :- 09.02.2008; Balance holding :- 154500
Jan 2008
28 Jan · Business
Press release, titled "Divi's Labs PAT for Q3 grows by 216% to Rs.99 crores". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.28 Jan · Results
Consolidated Results for the quarter ended on 31-DEC-2007 as follows: Net Sales of Rs. 28413 lacs for quarter ending on 31-DEC-2007 against Rs. 14951 lacs for the quarter ending on 31-DEC-2006. Net Profit / (Loss) of Rs. 9906 lacs for the quarter ending on 31-DEC-2007 against Rs. 3139 lacs for the quarter ending on 31-DEC-2006.28 Jan · Results
Standalone Results for the quarter ended on 31-DEC-2007 as follows: Net Sales of Rs. 28422 lacs for quarter ending on 31-DEC-2007 against Rs. 14962 lacs for the quarter ending on 31-DEC-2006. Net Profit / (Loss) of Rs. 10066 lacs for the quarter ending on 31-DEC-2007 against Rs. 3273 lacs for the quarter ending on 31-DEC-2006.19 Jan · Board meeting
Meeting on 28 Jan 2008: “Unaudited Financial Results for the qtr ended Dec 31, 2007”
Dec 2007
14 Dec · Disclosure
As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insider, who is Executive Director of the company has intimated on 10th December 2007, stating that he has gifted to his relative the following equity shares held by him in the company: (1) Name of the Director - N V Ramana; No. of Shares Gifted - 27340; Date of Execution - 10.12.2007; Balance holding - 20000
Oct 2007
27 Oct · Business
Press release which is as follows: "Divi's laboratories has earned a PAT of Rs.91 crores on consolidated basis for the second quarter ending 30th September, 2007. Total income for the quarter grew by 48% to Rs.245 crores. For the corresponding quarter of last year, the company earned a PAT of Rs.30 crores on a total income of Rs.165 crores. For the current half-year, Divi's earned a PAT of Rs.156 crores on income of Rs.475 crores as against a PAT of Rs.56 crores and income of Rs.330 crores during the corresponding previous half-year".27 Oct · Results
Consolidated Results for the half year ended on 30-SEP-2007 as follows: Net Sales of Rs. 47056 lacs for half year ending on 30-SEP-2007 against Rs. 32241.27 lacs for the half year ending on 30-SEP-2006. Net Profit / (Loss) of Rs. 15586 lacs for the half year ending on 30-SEP-2007 against Rs. 5553.91 lacs for the half year ending on 30-SEP-2006.27 Oct · Results
Consolidated Results for the quarter ended on 30-SEP-2007 as follows: Net Sales of Rs. 24384 lacs for quarter ending on 30-SEP-2007 against Rs. 16172.15 lacs for the quarter ending on 30-SEP-2006. Net Profit / (Loss) of Rs. 9097 lacs for the quarter ending on 30-SEP-2007 against Rs. 2990.5 lacs for the quarter ending on 30-SEP-2006.27 Oct · Results
Standalone Results for the quarter ended on 30-SEP-2007 as follows: Net Sales of Rs. 24251 lacs for quarter ending on 30-SEP-2007 against Rs. 16136.61 lacs for the quarter ending on 30-SEP-2006. Net Profit / (Loss) of Rs. 9125 lacs for the quarter ending on 30-SEP-2007 against Rs. 3128.22 lacs for the quarter ending on 30-SEP-2006.18 Oct · Board meeting
Meeting on 27 Oct 2007: “Unaudited Financial Results for the Qtr ended Sept 30, 2007”
Sep 2007
3 Sep · Meeting
Members of the Company passed the following resolution at the Annual General Meeting held on September 3, 2007. 1) Confirmed Interim dividend paid at Rs. 10/- each for equity shares as Dividend for the year. 2)Re-appointment of Dr. P. Gundu Rao, as Director liable to retire by rotation. 3) Re-appointment of Dr. K. Satyanarayana, as Director liable to retire by rotation. 4) Re-appointment of Mr. Kiran S. Divi, as Director liable to retire by rotation. 5) Re-appointment of M/s. P.V.R.K. Nageswara Rao & Co., Chartered Accountants , as Statutory Auditors of the Company to hold office till the conclusion of next AGM.